Singer Capital Markets is delighted to have been appointed as Nominated Adviser and Broker to Oxford BioDynamics plc with immediate effect.
Oxford Biodynamics’ portfolio of clinical smart tests based on EpiSwitch® technology aims to help people face the most challenging health decisions with confidence and tackle the rising costs of healthcare.
Ticker: OBD
Market Cap: £12.97million*
Website: Click here
*As of 17th February 2026
Account Team
| Investment Banking | |||
|---|---|---|---|
 Phil Davies Managing Director Email | Call |
 Anastassiya Eley Associate Email | Call |
||
| Research & Sales | |||
|---|---|---|---|
 Karl Keegan Head of Research Email | Call |
 Jonathan Dighe Equity Sales Email | Call |
 Edward Sham Equity Research Analyst Email | Call |
|
| Investor Relations | |||
|---|---|---|---|
 Kimberley Marks Investor Relations Email | Call |
|||
Let’s Talk
If you’re looking for more information about any of our services, or if you can’t find what you’re looking for directly on our site, please do not hesitate to contact us.
